Elsevier

Maturitas

Volume 150, August 2021, Pages 22-29
Maturitas

Hysterectomy, non-malignant gynecological diseases, and the risk of incident hypertension: The E3N prospective cohort

https://doi.org/10.1016/j.maturitas.2021.06.001Get rights and content

Highlights

  • In this study, hysterectomy, with or without oophorectomy, was associated with an increased risk of hypertension.

  • Endometriosis was associated with an increased risk of hypertension.

  • A history of uterine fibroids was associated with an increased risk of hypertension.

  • Associations between hypertension and non-malignant gynecological diseases were independent of a history of hysterectomy.

Abstract

Objectives

While it has been reported that women with uterine fibroids or endometriosis are commonly overweight and hypertensive, the association between non-malignant gynecological diseases and the risk of hypertension has been little studied prospectively. The aim of this study was to investigate in a large French cohort of women whether a history of hysterectomy, uterine fibroids, or endometriosis was prospectively related to an increased risk of incident hypertension.

Study design

We analyzed 50,286 women from the E3N cohort who were free of hypertension at baseline, with a median follow-up of 16.4 years.

Main outcome measures

Gynecological diseases were based on self-report. Cox proportional hazards models with age as the timescale were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Covariates included smoking status, body mass index (BMI), physical activity, and hormonal factors.

Results

A total of 12,073 women (24%) developed hypertension during follow-up. Women with a history of hysterectomy had an increased risk of incident hypertension, which persisted after adjustment for potential confounding factors (adjusted HR=1.18, 95% CI 1.12–1.24). Risk was similar in women with hysterectomy with or without oophorectomy. Risk of hypertension was higher in women with a history of endometriosis (HRendometriosis 1.19, 95%CI 1.11–1.22) or uterine fibroids (HRfibroids 1.18, 95%CI 1.13–1.22), irrespective of hysterectomy. Associations were similar after further adjustment for BMI.

Conclusions

Hysterectomy and non-malignant gynecological diseases were associated with an increased risk of hypertension in this large prospective study. Women with these conditions may benefit from blood pressure monitoring.

ClinicalTrials.gov identifier: NCT03285230

Introduction

Hypertension is the main risk factor for cardiovascular diseases (CVD), which are the primary cause of death in women [1]. Recent epidemiological studies have shown that the proportion of deaths attributable to CVD is higher in women (49%) than in men (40%) [1]. An increase in the incidence of CVD has been observed in younger women (under 60 years old) due to the modernization of lifestyle over the past decades [1, 2]. Better knowledge is therefore needed to fill the gender gap and improve cardiovascular health in women [3].

Hypertension affects 26% of the world population with a steady increase in prevalence [4,5]. It is often silent, underdiagnosed, and undertreated, especially in women [5, 6]. Hypertension is more frequent in women after menopause than in men [4] and has a more deleterious impact on the risk of cardiovascular events in women as compared to men [7, 8]. Identification of risk factors for hypertension is therefore crucial to early diagnose and manage hypertension in order to prevent its cardiovascular complications [3]. Several female-specific risk factors for hypertension have been identified, including preeclampsia and use of oral contraceptives [3]. Other factors such as hysterectomy or non-malignant gynecological disease could also be associated with the risk of hypertension but results from previous studies are unclear [9], [10], [11], [12], [13], [14], [15].

Hysterectomy is one of the most common gynecological procedures and is most often performed in case of non-malignant diseases such as fibroma or endometriosis [16, 17]. Women undergoing this surgery may experience metabolic changes by losing the protective effect of estrogens on cardiovascular health [18, 19]. An association between hysterectomy, with or without oophorectomy, and hypertension and cardiovascular risk has been reported in previous studies [9], [10], [11], [12], but results are inconsistent. Risk of hypertension was increased after hysterectomy in some studies [9, 11, 12] but not in all studies [10]. Most of these studies were based on small population without prospective follow-up and did not analyze major potential confounding such as body mass index (BMI), often increased in women with hysterectomy [11], and use of hormone replacement therapy (HRT).

Similarly, associations between non-malignant gynecological conditions, such as endometriosis and fibroids, and the risk of hypertension are unclear, and the confounding or mediating effects by other risk factors or by hysterectomy, frequent treatment of these diseases, are still unknown [11, [13], [14], [15], [20], [21], [22], [23]]. Additional large cohort studies are warranted to confirm the association between these conditions and the risk of incident hypertension.

This study aimed to prospectively assess the association between hysterectomy, non-malignant gynecological diseases (uterine fibroids and endometriosis), and the risk of incident hypertension in a large prospective cohort of French women.

Section snippets

The E3N cohort

The E3N study (Etude Epidémiologique de Femmes de la Mutuelle Générale de l'Education Nationale) is a French prospective cohort started in 1990. The study included 98,995 women aged 40–65 years at baseline and insured by a health insurance plan for workers in the National Education System and their families [24]. Participants have completed self-administered questionnaires with a mean response rate of 83% and total loss to follow-up since 1990 of less than 3%. Questionnaires were completed

Results

Mean age of women at the beginning of follow-up was 50.0 ± 6.2 years. Among 50,286 women considered in the study, 12,073 cases of hypertension were diagnosed during 669,947 person-years (PY) of observation (median follow-up duration of 8.8 [4.3–12] years for cases and 16.3 [14.9–16.4] years for non-cases) at a rate of 18.0 cases per 1000 PY. Mean age at the diagnosis of hypertension was 59.5 +/- 7.9 years. As shown in Table 1, women with a history of hysterectomy were more likely to have a

Discussion

In this large prospective cohort study, we found a positive association between a history of hysterectomy, with or without oophorectomy, and risk of incident hypertension, after adjustment for body mass index, diabetes, smoking status, physical activity and hormonal and reproductive factors including use of MHT and age at menopause. We also observed an association between a history of fibroid or endometriosis and the risk of hypertension, including in the absence of hysterectomy.

Conclusions

In this large prospective cohort study, women with a history of non-malignant gynecological pathology (hysterectomy, uterine fibroids, or endometriosis) had an increased risk of developing incident hypertension. These findings suggest that women with non-malignant gynecological conditions should be offered surveillance and screening of hypertension for earlier identification and management as hypertension is still underdiagnosed. Increased knowledge and awareness of female specificities in

Contributors

Anne-Laure Madika contributed to conceptualization, methodology, formal analysis and investigation, and was responsible for writing the original draft. Conor James MacDonald contributed to methodology. Amandine Gelot contributed to methodology, formal analysis and investigation. Sixtine Hitier contributed to conceptualization. Claire Mounier-Vehier contributed to conceptualization. Guillaume Béraud contributed to conceptualization and methodology. Marina Kvaskoff contributed to

Funding

This study was supported the Fédération Française de Cardiologie.

Ethical approval

All women provided written informed consent and the study was approved by the French National Commission for Data Protection and Individual Freedom, CNIL n°327346V 13, CPP (03/12/2008).

Provenance and peer review

This article was not commissioned and was externally peer reviewed.

Research data (data sharing and collaboration)

There are no linked research data sets for this paper. Data will be made available on request.

Declaration of Competing Interest

The authors declare that they have no conflict of interest.

References (45)

  • L. Mosca et al.

    Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update

    Circulation

    (2011)
  • Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19•1 million participants

    Lancet

    (2017)
  • Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys

    Lancet

    (2019)
  • R. Cífková et al.

    Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry

    J. Hypertens.

    (2019)
  • J. Boggia et al.

    Ambulatory Blood Pressure Monitoring in 9357 Subjects From 11 Populations Highlights Missed Opportunities for Cardiovascular Prevention in Women

    Hypertension

    (2011)
  • S.K. Laughlin-Tommaso et al.

    Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation

    Menopause

    (2016)
  • D.-.C. Ding et al.

    Risk of hypertension after hysterectomy: a population-based study

    BJOG An Int. J. Obstet. Gynaecol.

    (2018)
  • M. Fan et al.

    Association Between Endometriosis and Hypercholesterolemia or Hypertension

    Hypertension

    (2017)
  • Y.C. Haan et al.

    Hypertension Risk in Dutch Women With Symptomatic Uterine Fibroids

    Am. J. Hypertens.

    (2015)
  • Y.C. Haan et al.

    The risk of hypertension and cardiovascular disease in women with uterine fibroids

    J. Clin. Hypertens. (Greenwich).

    (2018)
  • J.D. Wright et al.

    Nationwide trends in the performance of inpatient hysterectomy in the United States

    Obstet. Gynecol.

    (2013)
  • C.M. Farquhar et al.

    The association of hysterectomy and menopause: a prospective cohort study

    BJOG An Int. J. Obstet. Gynaecol.

    (2005)
  • Cited by (10)

    • Use of antidepressants following hysterectomy with or without oophorectomy: A national sample in the US

      2023, Maturitas
      Citation Excerpt :

      Although hysterectomy is a valid option for treating benign gynecological conditions, it is an intrusive surgical procedure with numerous side-effects, such as bleeding and reduced physical functioning [7–9]. Some studies have shown that hysterectomy was associated with increased long-term coronary heart disease and hypertension [10,11]. Depressive symptoms after hysterectomy have been extensively studied; however, the results reported were inconsistent between studies.

    • Risk factors for hypertension in women

      2022, Archives des Maladies du Coeur et des Vaisseaux - Pratique
    View all citing articles on Scopus
    View full text